The cell cycle gene centromere protein K ( CENPK ) contributes to the malignant progression and prognosis of prostate cancer.

This study provides novel molecular insights into the role of in castration-resistant PCa cells and reveals that an increase in expression may indicate shorter DFS and a poor prognosis for patients with PCa. Targeting may be a novel strategy for the treatment of PCa.